Variants of lipolysis-related genes in Korean patients with very high triglycerides

Chan Joo Lee; Chi Yoon Oum; Yunbeom Lee; Sungha Park; Seok Min Kang; Donghoon Choi; Yangsoo Jang; Ji Hyun Lee; Sang Hak Lee

doi:10.3349/ymj.2018.59.1.148

Variants of lipolysis-related genes in Korean patients with very high triglycerides

Chan Joo Lee, Chi Yoon Oum, Yunbeom Lee, Sungha Park, Seok Min Kang, Donghoon Choi, Yangsoo Jang, Ji Hyun Lee, Sang Hak Lee

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

We investigated the prevalence and characteristics of variants of five lipolysis-related genes in Korean patients with very high triglycerides (TGs). Twenty-six patients with TG levels >885 mg/dL were selected from 13545 Korean subjects. Five candidate genes, LPL, APOC2, GPIHBP1, APOA5, and LMF1, were sequenced by targeted next-generation sequencing. Predictions of functional effects were performed and matched against public databases of variants. Ten rare variants of three genes were found in nine (34.6%) patients (three in LPL, four in APOA5, and three in LMF1). Five were novel and all variants were suspected of being disease-caus-ing. Nine were heterozygous, and one (3.8%) had a homozygous rare variant of LPL. Six common variants of four genes were observed in 25 (96.2%) patients (one in LPL, one in GPIHBP1, two in APOA5, and two in LMF1). The c.G41T variant of GPIHBP1 and c.G533T variant of APOA5 were most frequent and found in 15 (57.7%) and 14 (53.8%) patients, respectively. Rare homozygous variants of the genes were very uncommon, while diverse rare heterozygous variants were commonly identified. Taken together, most study subjects may be manifesting the combined effects of rare heterozygous variants and common variants.

Original language	English
Pages (from-to)	148-153
Number of pages	6
Journal	Yonsei medical journal
Volume	59
Issue number	1
DOIs	https://doi.org/10.3349/ymj.2018.59.1.148
Publication status	Published - 2018 Jan

Bibliographical note

Funding Information:
This research was financially supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2012R1A4A1029061 and 2014R1A1A2056104) (SH Lee), the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9B6029138) (SH Lee), the National Research Council of Science & Technology (NST) grant by the Korean government (MSIP) (No. CAP-12-2-KBSI) (SH Lee), and Basic Science Research Program through the NRF funded by the Ministry of Science, ICT and future Planning (No: NRF-2015R1A2A2A03 006577 (JH Lee), and a grant from Kyung Hee University in 2016 (KHU-20160543) (JH Lee).

Publisher Copyright:
© Yonsei University College of Medicine 2018.

All Science Journal Classification (ASJC) codes

Medicine(all)

Access to Document

10.3349/ymj.2018.59.1.148

Cite this

@article{7426642841ee4d04b54ac139aec127b7,

title = "Variants of lipolysis-related genes in Korean patients with very high triglycerides",

abstract = "We investigated the prevalence and characteristics of variants of five lipolysis-related genes in Korean patients with very high triglycerides (TGs). Twenty-six patients with TG levels >885 mg/dL were selected from 13545 Korean subjects. Five candidate genes, LPL, APOC2, GPIHBP1, APOA5, and LMF1, were sequenced by targeted next-generation sequencing. Predictions of functional effects were performed and matched against public databases of variants. Ten rare variants of three genes were found in nine (34.6%) patients (three in LPL, four in APOA5, and three in LMF1). Five were novel and all variants were suspected of being disease-caus-ing. Nine were heterozygous, and one (3.8%) had a homozygous rare variant of LPL. Six common variants of four genes were observed in 25 (96.2%) patients (one in LPL, one in GPIHBP1, two in APOA5, and two in LMF1). The c.G41T variant of GPIHBP1 and c.G533T variant of APOA5 were most frequent and found in 15 (57.7%) and 14 (53.8%) patients, respectively. Rare homozygous variants of the genes were very uncommon, while diverse rare heterozygous variants were commonly identified. Taken together, most study subjects may be manifesting the combined effects of rare heterozygous variants and common variants.",

author = "Lee, {Chan Joo} and Oum, {Chi Yoon} and Yunbeom Lee and Sungha Park and Kang, {Seok Min} and Donghoon Choi and Yangsoo Jang and Lee, {Ji Hyun} and Lee, {Sang Hak}",

note = "Funding Information: This research was financially supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2012R1A4A1029061 and 2014R1A1A2056104) (SH Lee), the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9B6029138) (SH Lee), the National Research Council of Science & Technology (NST) grant by the Korean government (MSIP) (No. CAP-12-2-KBSI) (SH Lee), and Basic Science Research Program through the NRF funded by the Ministry of Science, ICT and future Planning (No: NRF-2015R1A2A2A03 006577 (JH Lee), and a grant from Kyung Hee University in 2016 (KHU-20160543) (JH Lee). Publisher Copyright: {\textcopyright} Yonsei University College of Medicine 2018.",

year = "2018",

month = jan,

doi = "10.3349/ymj.2018.59.1.148",

language = "English",

volume = "59",

pages = "148--153",

journal = "Yonsei Medical Journal",

issn = "0513-5796",

publisher = "Yonsei University College of Medicine",

number = "1",

}

TY - JOUR

T1 - Variants of lipolysis-related genes in Korean patients with very high triglycerides

AU - Lee, Chan Joo

AU - Oum, Chi Yoon

AU - Lee, Yunbeom

AU - Park, Sungha

AU - Kang, Seok Min

AU - Choi, Donghoon

AU - Jang, Yangsoo

AU - Lee, Ji Hyun

AU - Lee, Sang Hak

N1 - Funding Information: This research was financially supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2012R1A4A1029061 and 2014R1A1A2056104) (SH Lee), the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9B6029138) (SH Lee), the National Research Council of Science & Technology (NST) grant by the Korean government (MSIP) (No. CAP-12-2-KBSI) (SH Lee), and Basic Science Research Program through the NRF funded by the Ministry of Science, ICT and future Planning (No: NRF-2015R1A2A2A03 006577 (JH Lee), and a grant from Kyung Hee University in 2016 (KHU-20160543) (JH Lee). Publisher Copyright: © Yonsei University College of Medicine 2018.

PY - 2018/1

Y1 - 2018/1

N2 - We investigated the prevalence and characteristics of variants of five lipolysis-related genes in Korean patients with very high triglycerides (TGs). Twenty-six patients with TG levels >885 mg/dL were selected from 13545 Korean subjects. Five candidate genes, LPL, APOC2, GPIHBP1, APOA5, and LMF1, were sequenced by targeted next-generation sequencing. Predictions of functional effects were performed and matched against public databases of variants. Ten rare variants of three genes were found in nine (34.6%) patients (three in LPL, four in APOA5, and three in LMF1). Five were novel and all variants were suspected of being disease-caus-ing. Nine were heterozygous, and one (3.8%) had a homozygous rare variant of LPL. Six common variants of four genes were observed in 25 (96.2%) patients (one in LPL, one in GPIHBP1, two in APOA5, and two in LMF1). The c.G41T variant of GPIHBP1 and c.G533T variant of APOA5 were most frequent and found in 15 (57.7%) and 14 (53.8%) patients, respectively. Rare homozygous variants of the genes were very uncommon, while diverse rare heterozygous variants were commonly identified. Taken together, most study subjects may be manifesting the combined effects of rare heterozygous variants and common variants.

AB - We investigated the prevalence and characteristics of variants of five lipolysis-related genes in Korean patients with very high triglycerides (TGs). Twenty-six patients with TG levels >885 mg/dL were selected from 13545 Korean subjects. Five candidate genes, LPL, APOC2, GPIHBP1, APOA5, and LMF1, were sequenced by targeted next-generation sequencing. Predictions of functional effects were performed and matched against public databases of variants. Ten rare variants of three genes were found in nine (34.6%) patients (three in LPL, four in APOA5, and three in LMF1). Five were novel and all variants were suspected of being disease-caus-ing. Nine were heterozygous, and one (3.8%) had a homozygous rare variant of LPL. Six common variants of four genes were observed in 25 (96.2%) patients (one in LPL, one in GPIHBP1, two in APOA5, and two in LMF1). The c.G41T variant of GPIHBP1 and c.G533T variant of APOA5 were most frequent and found in 15 (57.7%) and 14 (53.8%) patients, respectively. Rare homozygous variants of the genes were very uncommon, while diverse rare heterozygous variants were commonly identified. Taken together, most study subjects may be manifesting the combined effects of rare heterozygous variants and common variants.

UR - http://www.scopus.com/inward/record.url?scp=85037558233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037558233&partnerID=8YFLogxK

U2 - 10.3349/ymj.2018.59.1.148

DO - 10.3349/ymj.2018.59.1.148

M3 - Article

C2 - 29214790

AN - SCOPUS:85037558233

SN - 0513-5796

VL - 59

SP - 148

EP - 153

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

IS - 1

ER -

Variants of lipolysis-related genes in Korean patients with very high triglycerides

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this